Real-World Study of Magnetic Resonance-guided Laser Interstitial Thermal Therapy for Drug-resistant Epilepsy

NAEnrolling by invitationINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

March 14, 2024

Primary Completion Date

March 14, 2025

Study Completion Date

March 14, 2026

Conditions

Drug Resistant Epilepsy

Interventions

DEVICE

Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT)

MRgLITT employs laser energy delivered through a stereotactically placed laser applicator to precisely ablate the epileptogenic tissue.

Trial Locations (1)

Beijing Tiantan Hospital, Beijing

All Listed Sponsors

lead

Beijing Tiantan Hospital

OTHER